Hosted on MSN1h
FDA approves AbbVie’s Emblaveo for intra-abdominal infections
AbbVie has received US Food and Drug Administration (FDA) approval for Emblaveo (aztreonam and avibactam) to be used in ...
Contract Pharma2h
AbbVie’s EMBLAVEO Approved by FDA for Treatment of Complicated Intra-Abdominal Infections
Addresses the significant threat of antimicrobial resistance.
infectiousdiseaseadvisor.com3h
Emblaveo Approved for Intra-Abdominal Infections in Patients With Limited Options
The FDA has approved Emblaveo with metronidazole for patients with complicated intra-abdominal infections and limited options.